DaVita Inc. (DVA) Stock Price, Quote & News

About DVA

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition... [Read more]

Industry Medical Care Facilities

Sector Healthcare

IPO Date Oct 31, 1995

Employees 70,000

Stock Exchange NYSE

Ticker Symbol DVA

Website https://www.davita.com

Full Company Profile

Financial Performance

In 2023, DaVita's revenue was $12.14 billion, an increase of 4.57% compared to the previous year's $11.61 billion. Earnings were $691.54 million, an increase of 23.40%.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for DVA stock is "Hold." The 12-month stock price forecast is $153.6, which is an increase of 3.27% from the latest price.

Price Target

$153.6

(3.27% upside)

Analyst Consensus: Hold

Stock Forecasts

News

Drop Johnson & Johnson, Pick These Steady Eddie Stocks?

If you are a Johnson & Johnson investor and have been enjoying the stock's steady dividends, it may be time to look elsewhere. As of this moment, we find DaVita - a healthcare company focused on kidne...

Other symbols: DUKJNJ

7 days ago - Forbes

DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering

DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita")announced today the pricing of its previously announced private offering (the "offering") of $1.0 billion aggregate principal a...

4 weeks ago - PRNewsWire

DaVita Inc. Announces Offering of $1.0 Billion Senior Notes

DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita")announced today that it has commenced a private offering (the "offering") of $1.0 billion aggregate principal amount of its sen...

4 weeks ago - PRNewsWire

DaVita Inc. 2nd Quarter 2024 Results

DENVER , Aug. 6, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June30, 2024. "On behalf of all the teammates who provide life-saving car...

4 weeks ago - PRNewsWire

DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call

DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announcedtoday that it will hold its quarterly conference call to discuss second quarter results onTuesday, August 6, 2024, at5:00 p....

7 weeks ago - PRNewsWire

Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research

Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory...

Other symbols: MDT

7 weeks ago - GlobeNewsWire

US FTC probing DaVita, Fresenius Medical, Politico reports

The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors, P...

Other symbols: FMS

7 weeks ago - Reuters

DaVita, Nuwellis Extend Pilot Collaboration for Aquadex

DaVita DVA recently extended the pilot phase of a previously announced supply and collaboration agreement with NuwellisNUWE until Aug 31, 2024.At the conclusion of the pilot phase, DaVita may extend ...

Other symbols: NUWE

3 months ago - Benzinga

DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report

DENVER , May 14, 2024 /PRNewswire/ --Today, DaVita(NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new...

4 months ago - PRNewsWire

DaVita Appoints New Chief Information Officer

Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita DENVER , May 13, 2024 /PRNewswire/ -- DaVita,a leading provider of kidney care services, today announce...

4 months ago - PRNewsWire

DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference

DENVER , May 9, 2024 /PRNewswire/ --DaVita Inc.(NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will part...

4 months ago - PRNewsWire

DaVita Honors 54 Nephrology Nurses with DAISY Awards

Award celebrates excellence in nursing, underscoring the kidney care provider's commitment to recognizing the indelible impact of clinicians on outstanding patient care DENVER , May 9, 2024 /PRNewswir...

4 months ago - PRNewsWire

DaVita gains after upbeat quarterly profit prompts annual forecast raise

DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell.

4 months ago - Reuters

DaVita Inc. 1st Quarter 2024 Results

DENVER , May 2, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March31, 2024. "Through the first quarter, we continued building on the mo...

4 months ago - PRNewsWire

Best blue chip healthcare stocks to buy and hold in 2024

The healthcare industry is one of the biggest in the United States and other countries. In the US, the total Medicare expenditure stood at over $927 billion in 2022 and the trend is continuing as the ...

Other symbols: HCAISRG

4 months ago - Invezz